A detailed history of Ironwood Investment Management LLC transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Ironwood Investment Management LLC holds 156,070 shares of GRTS stock, worth $4,682. This represents 0.05% of its overall portfolio holdings.

Number of Shares
156,070
Previous 150,087 3.99%
Holding current value
$4,682
Previous $93,000 3.23%
% of portfolio
0.05%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.45 - $0.71 $2,692 - $4,247
5,983 Added 3.99%
156,070 $90,000
Q2 2024

Aug 16, 2024

SELL
$0.62 - $2.35 $4,659 - $17,662
-7,516 Reduced 4.77%
150,087 $93,000
Q1 2024

May 15, 2024

BUY
$1.96 - $2.9 $308,901 - $457,048
157,603 New
157,603 $405,000

Others Institutions Holding GRTS

About Gritstone bio, Inc.


  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Ironwood Investment Management LLC Portfolio

Follow Ironwood Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ironwood Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ironwood Investment Management LLC with notifications on news.